Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2017 ◽
Vol 18
(10)
◽
pp. 1411-1422
◽
2020 ◽
Vol 49
◽
pp. 102351
◽
Keyword(s):
2019 ◽
Vol 29
(2)
◽
pp. 357-367
◽
Keyword(s):
2005 ◽
Vol 95
(2)
◽
pp. 175-180
◽
2011 ◽
Vol 17
◽
pp. S24
◽
Keyword(s):
Keyword(s):